Systematic Financial Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.4M	Buy	376,079 +71,853	+24%	+$3.66M	0.45%	88
2025 Q4	$15.1M	Buy	304,226 +11,966	+4%	+$582K	0.36%	109
2025 Q3	$14M	Buy	292,260 +46,715	+19%	+$1.88M	0.34%	116
2025 Q2	$7.74M	Buy	245,545 +79,041	+47%	+$2.53M	0.21%	135
2025 Q1	$5.45M	Buy	166,504 +53,004	+47%	+$1.88M	0.16%	149
2024 Q4	$4.1M	Buy	113,500 +85,315	+303%	+$3M	0.1%	159
2024 Q3	$879K	Buy	+28,185	New	+$880K	0.02%	225
2020 Q3	–	Sell	-14,110	Closed	-$335K	–	425
2020 Q2	$335K	Sell	14,110 -7,470	-35%	-$165K	0.02%	246
2020 Q1	$388K	Sell	21,580 -6,085	-22%	-$128K	0.02%	230
2019 Q4	$656K	Buy	27,665 +9,280	+50%	+$225K	0.03%	256
2019 Q3	$505K	Sell	18,385 -10,900	-37%	-$323K	0.02%	397
2019 Q2	$969K	Buy	+29,285	New	+$1M	0.04%	296